Cargando…
High-throughput metabolomics and ingenuity pathway approach reveals the pharmacological effect and targets of Ginsenoside Rg1 in Alzheimer’s disease mice
Ginsenoside Rg1, a natural triterpenoid saponins compound isolated from the Panax species, has been found to possess neuroprotective properties in neurodegenerative diseases such as Alzheimer’s disease (AD). However, its pharmacological mechanism on AD has not been studied. In this study, an ultra-p...
Autores principales: | Li, Ge, Zhang, Ning, Geng, Fang, Liu, Guoliang, Liu, Bin, Lei, Xia, Li, Guang, Chen, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504884/ https://www.ncbi.nlm.nih.gov/pubmed/31065079 http://dx.doi.org/10.1038/s41598-019-43537-4 |
Ejemplares similares
-
Pharmacological activities of ginsenoside Rg5 (Review)
por: Liu, Ming-Yang, et al.
Publicado: (2021) -
A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's disease
por: Li, Naijing, et al.
Publicado: (2016) -
Cellular and molecular mechanisms underlying the action of ginsenoside Rg1 against Alzheimer's disease☆
por: Li, Xi, et al.
Publicado: (2012) -
Ginsenoside Rg1 ameliorates Alzheimer's disease pathology via restoring mitophagy
por: Wang, Ni, et al.
Publicado: (2023) -
Serum metabolomics reveal pathways associated with protective effect of ginsenoside Rg3 on immune stress
por: Bi, Shicheng, et al.
Publicado: (2022)